SEC Form S-8 filed by Mind Medicine (MindMed) Inc.
SECURITIES AND EXCHANGE COMMISSION
UNDER
THE SECURITIES ACT OF 1933
|
British Columbia, Canada
(State or other jurisdiction of
incorporation or organization) |
| |
98-1582438
(I.R.S. Employer
Identification Number) |
|
|
One World Trade Center, Suite 8500
New York, New York
(212) 220-6633 (Address of Principal Executive Offices) |
| |
10007
(Zip Code) |
|
MIND MEDICINE (MINDMED) INC. PERFORMANCE AND RESTRICTED SHARE UNIT PLAN
MIND MEDICINE (MINDMED) INC. EMPLOYEE SHARE PURCHASE PLAN
(Full titles of the plans)
Chief Legal Officer
Mind Medicine (MindMed) Inc.
(Name and address of agent for service)
(Telephone number, including area code, of agent for service)
|
Steven J. Abrams
Hogan Lovells US LLP 1735 Market Street Suite 2300 Philadelphia, Pennsylvania 19103 (267) 675-4600 |
| |
Trevor Scott
Osler, Hoskin & Harcourt LLP Suite 3000, Bentall Four 1055 Dunsmuir Street Vancouver, British Columbia, Canada V7X 1K8 (778) 785-3000 |
|
| Large accelerated filer | | | ☐ | | | Accelerated filer | | | ☐ | |
| Non-accelerated filer | | | ☒ | | | Smaller reporting company | | | ☒ | |
| | | | | | | Emerging growth company | | | ☒ | |
|
Exhibit
Number |
| |
Description
|
| |
Form
|
| |
Exhibit
No. |
| |
Incorporated by
Reference Filing Date |
| |
File No.
|
|
|
4.1
|
| | | |
8-K
|
| |
3.1
|
| |
June 30, 2022
|
| |
001-40360
|
| |
|
4.2
|
| | | |
10-K
|
| |
3.2
|
| |
February 28, 2024
|
| |
001-40360
|
| |
|
4.3
|
| | | |
10-K
|
| |
4.2
|
| |
March 9, 2023
|
| |
001-40360
|
| |
|
5.1*
|
| | | | | | | | | | | | | | | |
|
23.1*
|
| | | | | | | | | | | | | | | |
|
23.2*
|
| | | | | | | | | | | | | | | |
|
24.1*
|
| | | | | | | | | | | | | | | |
|
99.1
|
| | | |
10-K
|
| |
10.15
|
| |
March 9, 2023
|
| |
001-40360
|
| |
|
99.2
|
| | | |
10-K
|
| |
10.16
|
| |
March 9, 2023
|
| |
001-40360
|
| |
|
99.3
|
| | | |
10-K
|
| |
10.17
|
| |
March 9, 2023
|
| |
001-40360
|
| |
|
99.4
|
| | | |
10-K
|
| |
10.4
|
| |
March 28, 2022
|
| |
001-40360
|
| |
|
99.5*
|
| | | | | | | | | | | | | | | |
|
107*
|
| | | | | | | | | | | | | | |
Chief Executive Officer
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Robert Barrow
Robert Barrow
|
| |
Chief Executive Officer and Director
(Principal Executive Officer) |
| |
June 28, 2024
|
|
|
/s/ Carrie F. Liao
Carrie F. Liao, CPA
|
| |
Chief Accounting Officer
(Principal Financial Officer and Principal Accounting Officer) |
| |
June 28, 2024
|
|
|
/s/ Suzanne Bruhn
Suzanne Bruhn, PhD
|
| | Director | | |
June 28, 2024
|
|
|
/s/ David Gryska
David Gryska
|
| | Director | | |
June 28, 2024
|
|
|
/s/ Roger Crystal
Roger Crystal, MD
|
| | Director | | |
June 28, 2024
|
|
|
/s/ Andreas Krebs
Andreas Krebs
|
| | Director | | |
June 28, 2024
|
|
|
/s/ Carol A. Vallone
Carol A. Vallone
|
| | Director | | |
June 28, 2024
|
|
Chief Legal Officer & Corporate Secretary